Form 4: American Express Executive Anna Marrs Executes Stock Option and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Anna Marrs, Group President, GMNS at American Express, exercised stock options and sold shares of common stock on March 4, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

  • On March 4, 2025, Anna Marrs, a Group President at American Express, exercised stock options to acquire 16,274 shares of common stock at a price of $177.06 per share.
  • Simultaneously, Marrs sold a total of 21,245 shares of American Express common stock on the same day.
  • The sales were executed in multiple transactions at varying prices, ranging from $285 to $291.50 per share.
  • These transactions were conducted under a pre-arranged 10b5-1 trading plan adopted on December 3, 2024.
  • Following these transactions, Marrs directly owns 25,760.534 shares of American Express common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing reflects routine transactions under a pre-arranged trading plan. There's no indication of positive or negative implications for the company's performance.

Positives

  • The transactions were executed under a pre-arranged 10b5-1 trading plan, which can mitigate concerns about insider trading.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The use of a 10b5-1 trading plan is a common practice to allow insiders to sell shares without raising concerns about trading on non-public information.

Comparison to Industry Standards

  • Comparing the trading activity to other executives in similar financial services companies would provide a benchmark.
  • Analyzing the frequency and volume of insider trading activity at companies like Visa or Mastercard could offer context.
  • The use of 10b5-1 plans is widespread among public companies, and the details of this plan are consistent with standard practices.

Stakeholder Impact

  • The transactions have a minimal direct impact on stakeholders as they are part of a pre-planned trading strategy.

Key Dates

DateDescription
2024-12-03Date of adoption of the 10b5-1 Trading Plan
2025-01-28Date Employee Stock Option is exercisable
2025-01-28Date Employee Stock Option is exercisable
2025-03-04Date of stock option exercise and share sales
2025-03-06Date of Form 4 filing
2032-01-28Expiration date of Employee Stock Option

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.